Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

Inclusion Criteria: * Patients with at least 1 positive blood culture to MRSA within 72h up to randomization * Adult patients, equal or older than 18 years old * Signed informed consent * Mandatory use of contraception methods for fertile women during the study period and for 6 months after stopping antibiotic therapy Exclusion Criteria: * Polymicrobial bacteremia * Pneumonia associated to the bacteremia * Severe clinical status with expected survival of less than 24 hours * Allergy to daptomycin or fosfomycin * A positive pregnancy test at the time of inclusion * Any clinical condition that requires additional antibiotic therapy with microbiological activity against MRSA * Patient already included in another clinical trial * Prior history of eosinophilic pneumonia